This message was sent to ##Email##
|
|
|
|
|
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 15, 2019. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
AST
Where does the AST receive its funding? What percentage of AST members donate to the Society? These questions and more are answered in our latest blog post.
READ MORE
AST
The 2018 COP giving contest: The Donation Derby is under way! Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count towards this contest, so be sure to check it out today.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
AST
Visit the AST Member Spotlight page to find out what Rowena Delos Santos values most about her work in transplant nephrology.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
READ MORE
AST
Now through November 30, 2018, the AST is accepting nominations for its 2019 Board of Directors. If you are interested in joining the AST board, or know someone who is, we encourage you to submit your nomination.
READ MORE
|
|
AST
Join us for an interactive discussion on personalized medicine at the 2019 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. Early bird registration is now open.
READ MORE
|
The study is designed to explore an investigational drug-maribavir-in stem cell transplant and solid organ transplant recipients whose CMV infections are not responding to current treatments. This investigational drug is given as an oral pill. Please visit to learn more about the SOLSTICE study.
|
|
|
|
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. LEARN MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
| Upcoming Education Events
|
    |
AST
Transplant Metrics - Should We Enforce or Rewrite the Final Rule?
November 14, 2018 | 2 pm ET | Online Activity
For more information, click here.
Inhibiting inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance
November 15, 2018 | 4 pm ET | Online Activity
For more information, click here.
Psychosocial Aspects of Transition of the Newly Adult, New Patient
November 28, 2018 | 2 pm ET | Online Activity
For more information, click here.
AST
Significance, Identification and Treatment of Post-Thoracic Transplant Circulating Antibodies
After participating in this webinar, the learner will be able to:
- Describe the significance of post-transplant donor-specific antibodies (DSA) in the lung transplant recipients.
- Discuss techniques used to identify post-transplant DSA in lung transplant recipients.
- Describe possible therapeutic options used in a lung transplant recipient with DSA.
READ MORE
AST
An education committee subcommittee focusing on community education has recently been developed. They ask that you please share the following survey link with your patients, donors, and caregivers to help guide their efforts.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
Liver Transplantation
Bariatric surgery (BS) is effective in treating morbid obesity but the impact of prior BS on candidacy for liver transplantation (LT) is unclear. We examined 78 cirrhotic patients with prior BS compared with a concurrent cohort of 156 patients matched by age, MELD score, and underlying liver disease. We compared rates of transplant denial after evaluation, delisting on the waitlist (WL) and survival after LT.
READ MORE
Liver Transplantation
Nonalcoholic Steatohepatitis(NASH) is one of the top three indications for liver transplantation in western countries. It is unknown whether renal dysfunction at the time of liver transplantation has any effect on post‐liver transplantation outcomes in recipients with NASH.
READ MORE
American Journal of Transplantation
Low T‐cell counts and acute rejection are associated with increased cardiovascular events (CVE); T cell depleting agents decrease both. Thus, we aimed to characterize risk of CVE by induction agent used in kidney transplant recipients. We conducted a secondary data analysis of those with Medicare as their primary insurance from 1999‐2010.
READ MORE
American Journal of Transplantation
The replication kinetics of non‐pathogenic anelloviruses belonging to the Alphatorquevirus genus (such as torque teno virus [TTV]) might reflect the overall state of post‐transplant immunosuppression. We analysed 221 kidney transplant (KT) recipients in which plasma alphatorquevirus DNA load was quantified by real‐time PCR at baseline and regularly through the first 12 post‐transplant months.
READ MORE
American Journal of Transplantation
Face vascularized composite allografts (FVCA) have helped severe patient disfigurement, with acute rejection now largely controlled through iatrogenic immunosuppression. However, little is known regarding the incidence and mechanism(s) of more long‐term pathologic alterations in FVCAs that may affect function and graft durability.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
